El tratamiento de síndromes coronarios agudos de ancianos y pacientes con comorbilidades

Translated title of the contribution: Treatment of acute coronary syndromes in the elderly and in patients with comorbidities

Stefano Savonitto, Nuccia Morici, Stefano De Servi

Research output: Contribution to journalArticle

Abstract

Acute coronary syndromes have a wide spectrum of clinical presentations and risk of adverse outcomes. A distinction should be made between treatable (extent of ischemia, severity of coronary disease and acute hemodynamic deterioration) and untreatable risk (advanced age, prior myocardial damage, chronic kidney dysfunction, other comorbidities). Most of the patients with «untreatable» risk have been excluded from the «guideline- generating» clinical trials. In recent years, despite the paucity of specific randomized trials, major advances have been completed in the management of elderly patients and patients with comorbidities: from therapeutic nihilism to careful titration of antithrombotic agents, a shift toward the radial approach to percutaneous coronary interventions, and also to less-invasive cardiac surgery. Further advances should be expected from the development of drug regimens suitable for use in the elderly and in patients with renal dysfunction, from a systematic multidisciplinary approach to the management of patents with diabetes mellitus and anemia, and from the courage to undertake randomized trials involving these high-risk populations. Full English text available from: www.revespcardiol.org/en.

Original languageSpanish
Pages (from-to)564-573
Number of pages10
JournalRevista Espanola de Cardiologia
Volume67
Issue number7
DOIs
Publication statusPublished - 2014

Fingerprint

Acute Coronary Syndrome
Comorbidity
Kidney
Fibrinolytic Agents
Patents
Percutaneous Coronary Intervention
Therapeutics
Thoracic Surgery
Coronary Disease
Anemia
Diabetes Mellitus
Ischemia
Hemodynamics
Clinical Trials
Guidelines
Pharmaceutical Preparations
Population

Keywords

  • Anemia
  • Diabetes mellitus
  • Kidney
  • Myocardial infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

El tratamiento de síndromes coronarios agudos de ancianos y pacientes con comorbilidades. / Savonitto, Stefano; Morici, Nuccia; De Servi, Stefano.

In: Revista Espanola de Cardiologia, Vol. 67, No. 7, 2014, p. 564-573.

Research output: Contribution to journalArticle

@article{eb1a3b97f82a4513b04e11ced517c38d,
title = "El tratamiento de s{\'i}ndromes coronarios agudos de ancianos y pacientes con comorbilidades",
abstract = "Acute coronary syndromes have a wide spectrum of clinical presentations and risk of adverse outcomes. A distinction should be made between treatable (extent of ischemia, severity of coronary disease and acute hemodynamic deterioration) and untreatable risk (advanced age, prior myocardial damage, chronic kidney dysfunction, other comorbidities). Most of the patients with «untreatable» risk have been excluded from the «guideline- generating» clinical trials. In recent years, despite the paucity of specific randomized trials, major advances have been completed in the management of elderly patients and patients with comorbidities: from therapeutic nihilism to careful titration of antithrombotic agents, a shift toward the radial approach to percutaneous coronary interventions, and also to less-invasive cardiac surgery. Further advances should be expected from the development of drug regimens suitable for use in the elderly and in patients with renal dysfunction, from a systematic multidisciplinary approach to the management of patents with diabetes mellitus and anemia, and from the courage to undertake randomized trials involving these high-risk populations. Full English text available from: www.revespcardiol.org/en.",
keywords = "Anemia, Diabetes mellitus, Kidney, Myocardial infarction",
author = "Stefano Savonitto and Nuccia Morici and {De Servi}, Stefano",
year = "2014",
doi = "10.1016/j.recesp.2014.02.010",
language = "Spagnolo",
volume = "67",
pages = "564--573",
journal = "Revista Espanola de Cardiologia",
issn = "0300-8932",
publisher = "Ediciones Doyma, S.L.",
number = "7",

}

TY - JOUR

T1 - El tratamiento de síndromes coronarios agudos de ancianos y pacientes con comorbilidades

AU - Savonitto, Stefano

AU - Morici, Nuccia

AU - De Servi, Stefano

PY - 2014

Y1 - 2014

N2 - Acute coronary syndromes have a wide spectrum of clinical presentations and risk of adverse outcomes. A distinction should be made between treatable (extent of ischemia, severity of coronary disease and acute hemodynamic deterioration) and untreatable risk (advanced age, prior myocardial damage, chronic kidney dysfunction, other comorbidities). Most of the patients with «untreatable» risk have been excluded from the «guideline- generating» clinical trials. In recent years, despite the paucity of specific randomized trials, major advances have been completed in the management of elderly patients and patients with comorbidities: from therapeutic nihilism to careful titration of antithrombotic agents, a shift toward the radial approach to percutaneous coronary interventions, and also to less-invasive cardiac surgery. Further advances should be expected from the development of drug regimens suitable for use in the elderly and in patients with renal dysfunction, from a systematic multidisciplinary approach to the management of patents with diabetes mellitus and anemia, and from the courage to undertake randomized trials involving these high-risk populations. Full English text available from: www.revespcardiol.org/en.

AB - Acute coronary syndromes have a wide spectrum of clinical presentations and risk of adverse outcomes. A distinction should be made between treatable (extent of ischemia, severity of coronary disease and acute hemodynamic deterioration) and untreatable risk (advanced age, prior myocardial damage, chronic kidney dysfunction, other comorbidities). Most of the patients with «untreatable» risk have been excluded from the «guideline- generating» clinical trials. In recent years, despite the paucity of specific randomized trials, major advances have been completed in the management of elderly patients and patients with comorbidities: from therapeutic nihilism to careful titration of antithrombotic agents, a shift toward the radial approach to percutaneous coronary interventions, and also to less-invasive cardiac surgery. Further advances should be expected from the development of drug regimens suitable for use in the elderly and in patients with renal dysfunction, from a systematic multidisciplinary approach to the management of patents with diabetes mellitus and anemia, and from the courage to undertake randomized trials involving these high-risk populations. Full English text available from: www.revespcardiol.org/en.

KW - Anemia

KW - Diabetes mellitus

KW - Kidney

KW - Myocardial infarction

UR - http://www.scopus.com/inward/record.url?scp=84903313659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903313659&partnerID=8YFLogxK

U2 - 10.1016/j.recesp.2014.02.010

DO - 10.1016/j.recesp.2014.02.010

M3 - Articolo

AN - SCOPUS:84903313659

VL - 67

SP - 564

EP - 573

JO - Revista Espanola de Cardiologia

JF - Revista Espanola de Cardiologia

SN - 0300-8932

IS - 7

ER -